Trupanion (TRUP): Should You Buy, Sell, or Hold After Q4 Results?
Trupanion’s Recent Performance: A Cause for Concern?
Over the last half-year, Trupanion shareholders have faced significant losses, with the stock tumbling 33.7% to its current price of $28.77. This decline has been fueled in part by lackluster quarterly earnings, leaving many investors uncertain about their next move.
Should you consider adding Trupanion to your portfolio, or does it pose unnecessary risk?
Why We’re Not Enthusiastic About Trupanion
Although the stock’s valuation has dropped, we’re holding off on recommending Trupanion. Here are two key reasons we believe there are more attractive options available—and a company we’d prefer to own instead.
1. Weak Book Value Growth Signals Limited Progress
Book value per share (BVPS) is a vital indicator for insurance businesses, reflecting the net asset value allocated to each share. It provides a snapshot of a company’s financial health and its capacity to fulfill policyholder commitments.
Unfortunately for investors, Trupanion’s BVPS has only managed to grow at an annual rate of 10.4% over the past two years, which is underwhelming.
Trupanion Quarterly Book Value per Share
2. Past Expansion Efforts Have Led to Losses
Return on equity (ROE) is a comprehensive measure of how well an insurer turns shareholder investments into profits. A strong ROE often means better returns for investors, whether through retained earnings, share buybacks, or dividends.
Trupanion’s average ROE over the last five years stands at negative 7.5%. This is not only poor in absolute terms, but also lags far behind many insurers who regularly achieve ROEs above 20%. These results suggest Trupanion lacks a meaningful competitive edge.
Trupanion Return on Equity
Our Verdict
While Trupanion is not a fundamentally flawed company, it doesn’t meet our investment criteria. After its recent decline, the stock is trading at 2.8 times its projected book value (or $28.77 per share). Investors willing to take on more risk may still find it appealing, but we believe the downside outweighs the potential rewards. We’re confident that better opportunities exist elsewhere. For example, consider one of our top picks in software and edge computing.
Stocks We Prefer Over Trupanion
Don’t Miss: This Week’s Top 6 Stock Picks — The current market is quickly distinguishing high-quality stocks from overpriced ones, with AI-driven shifts impacting entire sectors overnight. In such a fast-moving environment, you need more than just a list of promising companies.
Our AI-powered system identified Palantir before its 1,662% surge, AppLovin ahead of its 753% rally, and Nvidia prior to its 1,178% climb. Each week, it highlights six new stocks that meet these rigorous standards.
Our selections have included well-known names like Nvidia (up 1,326% from June 2020 to June 2025), as well as lesser-known companies such as Comfort Systems, which delivered a 782% return over five years.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Solana Risks 2022-Like Correction As Price Erases Recovery

Aylab Joins REI Network to Accelerate Scalable Web3 Infrastructure Growth
Amazon, Google And Microsoft Keep Anthropic AI For Clients Despite Pentagon Risk Label
XRP Price Stuck in Range as Whale Transfers and Derivatives Outflow Grow

